Biological E to amp up vaccine production with Rs 1,800-crore investment
As India cements Hyderabad’s status as the “Vaccine Capital of the World,” Biological E has revealed vaccine production expansion plans worth more than Rs 1,800 crore. More than 2,500 individuals in Genome Valley will gain employment as a ...
22 July, 2022
Read more